NS
MRNA icon

NBC Securities’s Moderna MRNA Stock Holding History

NBC Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5K Sell
279
-214
-43% -$11.1K ﹤0.01% 1663
2026
Q1 		$25K Sell
493
-49
-9% -$2.29K ﹤0.01% 1619
2025
Q4 		$16K Buy
542
+75
+16% +$2.04K ﹤0.01% 1859
2025
Q3 		$12.1K Buy
467
+311
+199% +$8.68K ﹤0.01% 1953
2025
Q2 		$4K Buy
156
+1
+0.6% +$26 ﹤0.01% 2164
2025
Q1 		$4K Buy
+155
New +$5.5K ﹤0.01% 1923
2024
Q4 		– Sell
-577
Closed -$38K – 1776
2024
Q3 		$38K Sell
577
-24
-4% -$2.2K ﹤0.01% 1256
2024
Q2 		$71K Sell
601
-553
-48% -$70K 0.01% 1039
2024
Q1 		$122K Sell
1,154
-68
-6% -$6.85K 0.01% 896
2023
Q4 		$121K Buy
1,222
+205
+20% +$17.2K 0.01% 891
2023
Q3 		$105K Buy
+1,017
New +$113K 0.01% 920

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

NBC Securities's MRNA Position: Q2 2026 in Review

NBC Securities reduced its Moderna (MRNA) stake by 43% in Q2 2026, selling an estimated $11.1K and leaving 279 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

NBC Securities first reported a position in MRNA in Q3 2023 and has held it in 11 quarters since. The position peaked at $122K in Q1 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • NBC Securities held 279 shares of Moderna worth $19.5K as of Q2 2026.
  • NBC Securities sold 214 Moderna shares in Q2 2026, an estimated $11.1K.
  • Moderna made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1663 holding.
  • NBC Securities first reported a position in Moderna in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Moderna position peaked at $122K in Q1 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.